EQRX

EQRx, Inc. Common Stock
EQRX

Delisted

EQRX was delisted on the 8th of November, 2023.

Back to rankings
 

About: EQRx Inc is a biotechnology company. the company has more than 10 programs in its pipeline, including clinical, preclinical and drug engineering targets for the treatment of oncology and immune-inflammatory conditions. The program includes Aumolertinib, Lerociclib, Sugemalimab, Nofazinlimab, and others.

Employees: 363

Healthcare Drug Manufacturers - General
Charts implemented using Lightweight Charts™